Skip to main content

Published locations for Early HER2+ early breast cancer: APHINITY follow-up confirms DFS benefit of add-on pertuzumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Early HER2+ early breast cancer: APHINITY follow-up confirms DFS benefit of add-on pertuzumab

User login

  • Reset your password
  • /content/early-her2-early-breast-cancer-aphinity-follow-confirms-dfs-benefit-add-pertuzumab
  • /hematology-oncology/article/236985/breast-cancer/early-her2-early-breast-cancer-aphinity-follow
  • /breast-cancer-icymi/article/236985/breast-cancer/early-her2-early-breast-cancer-aphinity-follow